214 related articles for article (PubMed ID: 28735510)
1. FXa inhibition by rivaroxaban modifies mechanisms associated with the pathogenesis of human abdominal aortic aneurysms.
Moñux G; Zamorano-León JJ; Marqués P; Sopeña B; García-García JM; Laich de Koller G; Calvo-Rico B; García-Fernandez MA; Serrano J; López-Farré A
Br J Clin Pharmacol; 2017 Dec; 83(12):2661-2670. PubMed ID: 28735510
[TBL] [Abstract][Full Text] [Related]
2. Factor Xa Inhibition by Rivaroxaban Modified Mitochondrial-Associated Proteins in Human Abdominal Aortic Aneurysms.
Zamorano-Leon JJ; Serna-Soto M; Moñux G; Freixer G; Zekri-Nechar K; Cabrero-Fernandez M; Segura A; Gonzalez-Cantalapiedra A; Serrano J; Farré AL
Ann Vasc Surg; 2020 Aug; 67():482-489. PubMed ID: 32173474
[TBL] [Abstract][Full Text] [Related]
3. Factor Xa inhibitor rivaroxaban suppresses experimental abdominal aortic aneurysm progression via attenuating aortic inflammation.
Ding Y; Li X; Zhou M; Cai L; Tang H; Xie T; Shi Z; Fu W
Vascul Pharmacol; 2021 Feb; 136():106818. PubMed ID: 33227452
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of oxidative stress in human aortic aneurysms--association with clinical risk factors for atherosclerosis and disease severity.
Guzik B; Sagan A; Ludew D; Mrowiecki W; Chwała M; Bujak-Gizycka B; Filip G; Grudzien G; Kapelak B; Zmudka K; Mrowiecki T; Sadowski J; Korbut R; Guzik TJ
Int J Cardiol; 2013 Oct; 168(3):2389-96. PubMed ID: 23506637
[TBL] [Abstract][Full Text] [Related]
5. Compression stockings attenuate the expression of proteins associated with vascular damage in human varicose veins.
Moñux G; Serna-Soto M; Plá-Sanchez F; Zamorano-León JJ; Segura A; Rial R; Freixer G; Zekri-Nechar K; Hugo-Martínez C; Serrano J; López-Farré A
J Vasc Surg Venous Lymphat Disord; 2021 Mar; 9(2):428-434. PubMed ID: 32679199
[TBL] [Abstract][Full Text] [Related]
6. Resveratrol prevents the development of abdominal aortic aneurysm through attenuation of inflammation, oxidative stress, and neovascularization.
Kaneko H; Anzai T; Morisawa M; Kohno T; Nagai T; Anzai A; Takahashi T; Shimoda M; Sasaki A; Maekawa Y; Yoshimura K; Aoki H; Tsubota K; Yoshikawa T; Okada Y; Ogawa S; Fukuda K
Atherosclerosis; 2011 Aug; 217(2):350-7. PubMed ID: 21530968
[TBL] [Abstract][Full Text] [Related]
7. Alterations in phenotype and gene expression of adult human aneurysmal smooth muscle cells by exogenous nitric oxide.
Farrell K; Simmers P; Mahajan G; Boytard L; Camardo A; Joshi J; Ramamurthi A; Pinet F; Kothapalli CR
Exp Cell Res; 2019 Nov; 384(1):111589. PubMed ID: 31473210
[TBL] [Abstract][Full Text] [Related]
8. Effects of rivaroxaban and dabigatran on local expression of coagulation and inflammatory factors within human aortic stenotic valves.
Wypasek E; Natorska J; Mazur P; Kopytek M; Gawęda B; Kapusta P; Madeja J; Iwaniec T; Kapelak B; Undas A
Vascul Pharmacol; 2020 Jul; 130():106679. PubMed ID: 32387621
[TBL] [Abstract][Full Text] [Related]
9. Controlled release of ascorbic acid from gelatin hydrogel attenuates abdominal aortic aneurysm formation in rat experimental abdominal aortic aneurysm model.
Tanaka A; Hasegawa T; Morimoto K; Bao W; Yu J; Okita Y; Tabata Y; Okada K
J Vasc Surg; 2014 Sep; 60(3):749-58. PubMed ID: 24011462
[TBL] [Abstract][Full Text] [Related]
10. Targeting Coagulation Factor Xa Promotes Regression of Advanced Atherosclerosis in Apolipoprotein-E Deficient Mice.
Posthuma JJ; Posma JJN; van Oerle R; Leenders P; van Gorp RH; Jaminon AMG; Mackman N; Heitmeier S; Schurgers LJ; Ten Cate H; Spronk HMH
Sci Rep; 2019 Mar; 9(1):3909. PubMed ID: 30846818
[TBL] [Abstract][Full Text] [Related]
11. Oxidative stress in human abdominal aortic aneurysms: a potential mediator of aneurysmal remodeling.
Miller FJ; Sharp WJ; Fang X; Oberley LW; Oberley TD; Weintraub NL
Arterioscler Thromb Vasc Biol; 2002 Apr; 22(4):560-5. PubMed ID: 11950691
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of reactive oxygen species attenuates aneurysm formation in a murine model.
Xiong W; Mactaggart J; Knispel R; Worth J; Zhu Z; Li Y; Sun Y; Baxter BT; Johanning J
Atherosclerosis; 2009 Jan; 202(1):128-34. PubMed ID: 18502427
[TBL] [Abstract][Full Text] [Related]
13. Comparison of cell-type-specific vs transmural aortic gene expression in experimental aneurysms.
Sho E; Sho M; Nanjo H; Kawamura K; Masuda H; Dalman RL
J Vasc Surg; 2005 May; 41(5):844-52. PubMed ID: 15886670
[TBL] [Abstract][Full Text] [Related]
14. NADPH oxidase deficiency exacerbates angiotensin II-induced abdominal aortic aneurysms in mice.
Kigawa Y; Miyazaki T; Lei XF; Nakamachi T; Oguchi T; Kim-Kaneyama JR; Taniyama M; Tsunawaki S; Shioda S; Miyazaki A
Arterioscler Thromb Vasc Biol; 2014 Nov; 34(11):2413-20. PubMed ID: 25189573
[TBL] [Abstract][Full Text] [Related]
15. Mesenchymal Stem Cells Attenuate NADPH Oxidase-Dependent High Mobility Group Box 1 Production and Inhibit Abdominal Aortic Aneurysms.
Sharma AK; Salmon MD; Lu G; Su G; Pope NH; Smith JR; Weiss ML; Upchurch GR
Arterioscler Thromb Vasc Biol; 2016 May; 36(5):908-18. PubMed ID: 26988591
[TBL] [Abstract][Full Text] [Related]
16. Parenteral administration of factor Xa/IIa inhibitors limits experimental aortic aneurysm and atherosclerosis.
Moran CS; Seto SW; Krishna SM; Sharma S; Jose RJ; Biros E; Wang Y; Morton SK; Golledge J
Sci Rep; 2017 Feb; 7():43079. PubMed ID: 28220880
[TBL] [Abstract][Full Text] [Related]
17. Intermedin1-53 Attenuates Abdominal Aortic Aneurysm by Inhibiting Oxidative Stress.
Lu WW; Jia LX; Ni XQ; Zhao L; Chang JR; Zhang JS; Hou YL; Zhu Y; Guan YF; Yu YR; Du J; Tang CS; Qi YF
Arterioscler Thromb Vasc Biol; 2016 Nov; 36(11):2176-2190. PubMed ID: 27634835
[TBL] [Abstract][Full Text] [Related]
18. Spike Protein Subunits of SARS-CoV-2 Alter Mitochondrial Metabolism in Human Pulmonary Microvascular Endothelial Cells: Involvement of Factor Xa.
Zekri-Nechar K; Zamorano-León JJ; Reche C; Giner M; López-de-Andrés A; Jiménez-García R; López-Farré AJ; Martínez-Martínez CH
Dis Markers; 2022; 2022():1118195. PubMed ID: 36438904
[TBL] [Abstract][Full Text] [Related]
19. Expression of VEGFs and its receptors in abdominal aortic aneurysm.
Wolanska M; Bankowska-Guszczyn E; Sobolewski K; Kowalewski R
Int Angiol; 2015 Dec; 34(6):520-8. PubMed ID: 25968806
[TBL] [Abstract][Full Text] [Related]
20. Effects of factor Xa on the expression of proteins in femoral arteries from type 2 diabetic patients.
López-Farré AJ; Rodriguez-Sierra P; Modrego J; Segura A; Martín-Palacios N; Saiz AM; Zamorano-León JJ; Duarte J; Serrano J; Moñux G
Br J Clin Pharmacol; 2014 Dec; 78(6):1366-77. PubMed ID: 25041869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
